![]() |
市場調查報告書
商品編碼
1738799
全球實驗室離心機市場規模:按離心機類型、按應用、按最終用戶、按地區、範圍和預測Global Laboratory Centrifuge Market Size By Type of Centrifuge, By Application, By End-User, By Geographic Scope And Forecast |
2024 年實驗室離心機市場規模價值 11.7 億美元,預計到 2032 年將達到 14.2 億美元,2026 年至 2032 年的複合年成長率為 2.5%。
實驗室離心機是一種用於高速旋轉混合物成分並根據其密度進行分離的設備。旋轉產生的離心力使密度較大的顆粒移至管底外側,而密度較小的顆粒則留在管中心附近。
實驗室離心機是各行各業必不可少的工具,用於根據密度分離混合物。在臨床實驗室中,離心機在血液樣本的處理中發揮至關重要的作用,可以分離血漿和血清,這對於診斷測試和醫學研究至關重要。
在實驗室中,特別是在分子生物學和生物化學中,離心機用於分離和精製細胞、核酸、蛋白質和其他細胞成分,以促進各種實驗程序。
在製藥業,離心機用於在藥物開發和製造過程中分離和精製化合物。
環境測試實驗室使用離心機將環境樣本中的懸浮固體與液體分離,以協助污染監測和分析。
此外,食品和飲料行業的乳製品加工中還使用離心機來分離牛奶中的脂肪等成分,確保產品的品質和一致性。
技術進步:離心機技術的不斷創新,例如改進的轉子設計和數位介面,提高了運作效率、精度和用戶便利性,推動了市場成長。 2024年2月發表在《實驗室自動化雜誌》上的一項研究發現,採用先進轉子設計的新一代離心機將樣品處理速度提高了30%,同時噪音降低了40%。
臨床診斷需求不斷成長:疾病發病率的不斷上升以及對早期準確診斷的需求,刺激了臨床實驗室對用於處理血液和尿液樣本的實驗室離心機的需求。世界衛生組織 (WHO) 在 2023 年報告稱,過去五年全球診斷檢測量每年成長 8%。
生物技術和製藥業的成長:生物技術和製藥領域研究活動和藥物開發計劃的擴展,推動了對用於樣品製備和化合物精製的離心技術的需求。生技創新局報告稱,2023年生物技術領域的研發支出將達到1,020億美元,與前一年同期比較成長7%。
環境和食品安全測試:隨著人們對環境監測和食品安全測試的認知和監管要求的不斷提高,離心機的使用也越來越多,以分離污染物並確保符合標準。
主要挑戰
維護和營業成本:定期維護和潛在的維修需求會導致高昂的營運成本,這可能會阻礙實驗室投資新的離心機設備。美國臨床實驗室科學學會 (ACLSC) 2023 年的報告顯示,實驗室離心機的平均使用壽命為 7-10 年,運作五年後維護成本將顯著增加。
技術複雜性:先進的離心機系統非常複雜,需要熟練的人員來操作和維護,這對於面臨人員短缺和預算限制的實驗室來說是一個挑戰。美國勞工統計局報告稱,2023年合格實驗室技術人員的短缺率為5%,預計到2025年這一缺口將擴大到7%。
嚴格的監管要求:遵守嚴格的監管標準和認證流程可能會延遲產品上市並增加製造商的成本,從而影響市場動態。歐洲藥品管理局(EMA)在其2023年年度報告中指出,只有70%的檢測設備申請能夠獲得首次核准,凸顯了嚴格的審查流程。
開發中地區取得途徑有限:新興國家醫療基礎設施不足且財政資源有限,限制了實驗室離心機的普及,從而限制了這些地區的市場發展。世界衛生組織 (WHO) 報告稱,到 2023 年,低收入國家僅有 45% 的實驗室能夠使用現代化的離心機設備。
主要趨勢
體積小巧,方便攜帶:小型攜帶式離心機的趨勢日益成長,尤其是在照護現場和小型實驗室中。這種緊湊的設備能夠靈活地執行必要的離心任務,而無需使用更大的固定式儀器。美國病理學家協會 (College of 美國 Pathologists) 報告稱,到 2023 年,40% 的就地檢驗實驗室將採用攜帶式離心機,而 2020 年這一比例僅為 25%。
個人化醫療與基因組學:個人化醫療日益受到關注,基因組學研究也取得了進展,這推動了對精準專業離心技術的需求。這一趨勢正推動能夠滿足精細專業樣品處理需求的離心機的發展。例如,賽默飛世爾科技於2024年5月推出了專為次世代定序儀定序樣品製備而設計的GenomeSpin離心機系列。該公司聲稱,與標準離心機相比,這些設備可將DNA碎片化率降低40%。
物聯網與互聯互通:物聯網 (IoT) 功能的整合可實現遠端監控、即時數據分析以及更有效率的實驗室流程管理。這種互聯互通使實驗室能夠簡化業務並提高整體生產力。根據實驗室自動化協會 2023 年的一項調查,65% 的大型實驗室已部署支援物聯網的檢測設備(包括離心機),高於 2021 年的 45%。
Laboratory Centrifuge Market size was valued at USD 1.17 Billion in 2024 and is projected to reach USD 1.42 Billion by 2032, growing at a CAGR of 2.5% from 2026 to 2032.
A laboratory centrifuge is a device used to separate components of a mixture based on their density by spinning them at high speed. The centrifugal force generated by the rotation causes denser particles to move outward to the bottom of the tube, while lighter particles remain closer to the center.
Laboratory centrifuges are essential tools used in a variety of fields for the separation of mixtures based on density. In clinical laboratories, they play a critical role in processing blood samples, allowing for the separation of plasma or serum, which is vital for diagnostic tests and medical research.
In research laboratories, particularly in molecular biology and biochemistry, centrifuges are used to isolate and purify cells, nucleic acids, proteins, and other cellular components, facilitating a wide range of experimental procedures.
The pharmaceutical industry relies on centrifuges for the separation and purification of compounds during drug development and manufacturing processes.
Environmental testing laboratories use centrifuges to separate suspended solids from liquids in environmental samples, aiding in pollution monitoring and analysis.
Additionally, the food and beverage industry employs centrifuges to separate components such as fats from milk in dairy processing, ensuring product quality and consistency.
The key market dynamics that are shaping the global laboratory Centrifuge market include:
Technological Advancements: Continuous innovations in centrifuge technology, such as improved rotor designs and digital interfaces, enhance operational efficiency, accuracy, and user convenience, driving market growth. A study published in the Journal of Laboratory Automation in February 2024 found that new-generation centrifuges with advanced rotor designs improved sample processing speed by 30% while reducing noise levels by 40%.
Rising Demand for Clinical Diagnostics: The increasing prevalence of diseases and the need for early and accurate diagnosis fuel the demand for laboratory centrifuges in clinical laboratories for blood and urine sample processing. The World Health Organization (WHO) reported in 2023 that global diagnostic testing volumes increased by 8% annually over the past five years.
Growth in Biotechnology and Pharmaceutical Industries: Expanding research activities and drug development projects in the biotechnology and pharmaceutical sectors boost the need for centrifugation techniques for sample preparation and compound purification. The Biotechnology Innovation Organization reported in 2023 that R&D spending in the biotech sector reached $102 billion, a 7% increase from the previous year.
Environmental and Food Safety Testing: Heightened awareness and regulatory requirements for environmental monitoring and food safety testing lead to increased use of centrifuges to separate contaminants and ensure compliance with standards.
Key Challenges:
Maintenance and Operational Costs: Regular maintenance and the potential need for repairs can lead to high operational costs, which may deter laboratories from investing in new centrifuge equipment. The American Society for Clinical Laboratory Science reported in 2023 that the average lifespan of a laboratory centrifuge is 7-10 years, with maintenance costs increasing significantly after the fifth year of operation.
Technical Complexity: The complexity of advanced centrifuge systems requires skilled personnel for operation and maintenance, which can be a challenge for laboratories facing staff shortages or budget constraints. The U.S. Bureau of Labor Statistics reported in 2023 that there was a 5% shortage of qualified laboratory technicians, with the gap expected to widen to 7% by 2025.
Stringent Regulatory Requirements: Compliance with rigorous regulatory standards and certification processes can delay product launches and increase costs for manufacturers, impacting market dynamics. The European Medicines Agency (EMA) stated in its 2023 annual report that only 70% of laboratory equipment applications received initial approval, highlighting the stringent review process.
Limited Access in Developing Regions: Inadequate healthcare infrastructure and limited financial resources in developing regions restrict the adoption of laboratory centrifuges, constraining market expansion in these areas. The World Health Organization (WHO) reported in 2023 that only 45% of laboratories in low-income countries had access to modern centrifuge equipment.
Key Trends
Miniaturization and Portability: The trend towards smaller, portable centrifuges is gaining traction, particularly in point-of-care settings and smaller laboratories. These compact devices provide the flexibility to perform essential centrifugation tasks without the need for large, stationary equipment. The College of American Pathologists reported in 2023 that 40% of point-of-care testing sites had adopted portable centrifuges, up from 25% in 2020.
Personalized Medicine and Genomics: The increasing focus on personalized medicine and advancements in genomics research are driving the demand for precise and specialized centrifugation techniques. This trend is pushing the development of centrifuges that can handle delicate and specific sample processing needs. For instance, In May 2024, Thermo Fisher Scientific introduced its GenomeSpin centrifuge series, specifically designed for next-generation sequencing sample preparation. The company claims these devices can reduce DNA fragmentation by 40% compared to standard centrifuges.
Integration with IoT and Connectivity: The incorporation of Internet of Things (IoT) capabilities allows for remote monitoring, real-time data analysis, and better management of laboratory processes. This connectivity enables laboratories to streamline operations and improve overall productivity. A survey by the Association of Laboratory Automation in 2023 found that 65% of large laboratories had implemented IoT-enabled laboratory equipment, including centrifuges, up from 45% in 2021.
Here is a more detailed regional analysis of the global laboratory centrifuge market:
North America
North America holds a significant share of the global laboratory centrifuge market, driven by its advanced healthcare infrastructure, high research and development (R&D) expenditure, and the presence of major market players.
The region's robust biotechnology and pharmaceutical sectors further boost demand for laboratory centrifuges.
Additionally, the strong focus on clinical diagnostics and substantial government funding for research activities contribute to the region's leading position in the market.
North America's commitment to technological innovation and regulatory compliance ensures the adoption of state-of-the-art centrifuge technologies, supporting the growth and development of the laboratory centrifuge market in this region.
Asia Pacific
Asia-Pacific is the fastest-growing region in the laboratory centrifuge market, driven by expanding healthcare infrastructure, rising investments in biotechnology and pharmaceutical industries, and increasing R&D activities.
Countries like China, India, and Japan are major growth hubs, contributing significantly to market expansion.
The region is experiencing growing adoption of advanced and automated centrifuge systems, supported by increasing government initiatives to enhance healthcare research.
The focus on developing cost-effective solutions to ensure wider accessibility and the expanding capabilities of healthcare facilities further propel the demand for laboratory centrifuges in Asia-Pacific.
The Global Laboratory Centrifuge Market is Segmented on the basis of Type of Centrifuge, Application, End-User, and Geography.
Based on Type of Centrifuge, the Global Laboratory Centrifuge Market is bifurcated into Microcentrifuges, Benchtop Centrifuges, Floor Standing Centrifuges, and Ultracentrifuges. Benchtop centrifuges dominate the laboratory centrifuge market due to their versatility, compact size, and wide applicability across various laboratory settings. These centrifuges are commonly used for routine sample preparation, including clinical diagnostics, biotechnology research, and pharmaceutical applications. Their ease of use and cost-effectiveness make them highly preferred in both academic research institutes and diagnostic laboratories. Microcentrifuges are the rapidly growing segment, driven by their specialized application in molecular biology, genetics, and life sciences research.
Based on Application, the Global Laboratory Centrifuge Market is bifurcated into Biotechnology, Clinical Diagnostics, Pharmaceuticals, and Research. Clinical diagnostics dominates the laboratory centrifuge market due to the critical role centrifuges play in processing blood, urine, and other samples for diagnostic tests. These devices are essential for separating plasma or serum from whole blood, enabling accurate and timely diagnosis of various medical conditions, which drives their widespread adoption in hospitals and diagnostic laboratories. Biotechnology is the rapidly growing segment, fueled by increasing research activities and investments in areas such as genomics, proteomics, and molecular biology.
Based on End-User, the Global Laboratory Centrifuge Market is bifurcated into Hospitals and Diagnostic Centers, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes. Hospitals and diagnostic centers dominate the laboratory centrifuge market as they are the primary users of centrifuges for clinical diagnostics and medical testing purposes. These facilities require centrifuges to separate blood components, analyze samples, and conduct routine diagnostic procedures efficiently. The continuous demand for accurate and rapid diagnostic results drives the dominance of this segment in the market. Biotechnology and Pharmaceutical Companies are the rapidly growing segment, fueled by increasing investments in drug discovery, biopharmaceutical research, and molecular diagnostics.
Based on Geography, the Global Laboratory Centrifuge Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the laboratory centrifuge market, driven by its advanced healthcare infrastructure, high research and development (R&D) investments, and the presence of leading biotechnology and pharmaceutical companies. The region's robust adoption of advanced laboratory technologies and stringent regulatory standards further bolster its dominant position in the market. Asia Pacific is the rapidly growing segment in the laboratory centrifuge market, fueled by expanding healthcare facilities, increasing investments in biotechnology and pharmaceutical industries, and rising R&D activities.
The "Global Laboratory Centrifuge Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Thermo Fisher Scientific, Inc., Andreas Hettich GmbH & Co. KG, Danaher Corporation, Eppendorf AG, and HERMLE Labortechnik GmbH.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.